Medicine and Dentistry
Acute Hepatitis A
11%
Age
9%
Antivirus Agent
11%
Ascites
38%
Autoantigen
23%
Biopsy
15%
Budesonide
30%
Chronic Hepatitis B
37%
Chronic Hepatitis C
13%
Collagenous Colitis
28%
Combination Therapy
14%
Decompensated Liver Cirrhosis
13%
Diagnosis
16%
Diseases
27%
Electroencephalogram
9%
Follow up
18%
Grazoprevir
16%
Hepatic Encephalopathy
16%
Hepatitis B Virus
21%
Hepatitis C Virus
18%
Hepatocellular Carcinoma
44%
Hepatology
15%
Hepatorenal Syndrome
23%
Hyponatremia
23%
Incidence
20%
Inducible Nitric Oxide Synthase
15%
Inpatient
14%
Ischemic Heart Disease
15%
Liver
9%
Liver Cancer
23%
Liver Cirrhosis
38%
Maintenance Therapy
11%
Measurement
13%
Messenger RNA
15%
Microscopic Colitis
13%
Mortality
11%
Mortality Rate
10%
Nonstructural Protein 5A Inhibitor
9%
Pathophysiology
15%
Patient
94%
Person
46%
Prevalence
11%
Prophylaxis
15%
Relapse
9%
Ribavirin
23%
Serositis
9%
Spontaneous Bacterial Peritonitis
23%
Spontaneous Remission
11%
Survival
15%
Therapeutic Procedure
100%
Pharmacology, Toxicology and Pharmaceutical Science
All Cause Mortality
7%
Antivirus Agent
11%
Apoptosis
17%
Ascites
15%
Autoimmune Hepatitis
17%
B Cell Lymphoma
17%
Bacterial Peritonitis
23%
Budesonide
53%
Chronic Hepatitis B
37%
Chronic Hepatitis C
19%
Collagenous Colitis
51%
Complication
11%
Decompensated Liver Cirrhosis
13%
Diseases
19%
Elimination
15%
Grazoprevir
16%
Hepatitis B Virus
21%
Hepatitis C
12%
Hepatitis C Virus
29%
Hepatitis C Virus Genotype 1
11%
Hepatitis C Virus Genotype 3
23%
Hepatorenal Syndrome
23%
Hyponatremia
23%
Incidence
20%
Inducible Nitric Oxide Synthase
15%
Infection
14%
Inflammation
9%
Ischemic Heart Disease
15%
Liver Cancer
23%
Liver Cell Carcinoma
44%
Liver Cirrhosis
30%
Messenger RNA
15%
Microscopic Colitis
13%
Mortality
11%
Mortality Rate
10%
Nitric Oxide
7%
Nonstructural Protein 5A Inhibitor
9%
Pathogenesis
7%
Pathophysiology
7%
Peginterferon
17%
Placebo
23%
Prevalence
11%
Prognosis
15%
Relapse
9%
Remission
11%
Ribavirin
40%
Ruzasvir
16%
Survival
15%
Symptom
23%
Uprifosbuvir
16%
Nursing and Health Professions
All Cause Mortality
7%
Antivirus Agent
11%
Ascites
38%
Bacterial Peritonitis
23%
Budesonide
30%
Chronic Hepatitis B
37%
Chronic Hepatitis C
13%
Cohort Analysis
8%
Collagenous Colitis
34%
Complication
17%
Confidence Interval
15%
Control
8%
Decompensated Liver Cirrhosis
13%
Diagnosis
16%
Diagnostic Procedure
7%
Diseases
27%
Follow up
8%
Grazoprevir
16%
Hepatorenal Syndrome
23%
Hyponatremia
23%
Incidence
20%
Inpatient
7%
Ischemic Heart Disease
15%
Liver Cancer
23%
Liver Cirrhosis
29%
Liver Stiffness
13%
Measurement
13%
Messenger RNA
15%
Mortality
11%
Mortality Rate
10%
Nitric Oxide
7%
Nonstructural Protein 5A Inhibitor
9%
Pathophysiology
15%
Patient
46%
Person
34%
Polyacrylamide Gel Electrophoresis
9%
Population
8%
Practice Guideline
30%
Prognosis
23%
Prophylaxis
15%
Rate Ratio
14%
Relapse
7%
Ruzasvir
16%
Survival
15%
Time
9%
Uprifosbuvir
16%
